Status and phase
Conditions
Treatments
About
The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for Part A and B
Inclusion Criteria for Part C
Exclusion Criteria for Part A and B
Exclusion Criteria for Part C
Primary purpose
Allocation
Interventional model
Masking
162 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Amgen Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal